| インド | トルコ | オーストリア | |
| 腹腔内温熱化学療法 | から $9,500 | から $22,500 | から $40,000 |
| 大腸癌に対する放射線療法 | から $3,200 | から $7,000 | から $12,000 |
| 大網切除術 | から $3,200 | から $4,500 | から $15,000 |
| 卵巣癌手術 | から $5,800 | から $9,243 | から $25,000 |
| 卵巣摘出術 | から $3,400 | から $2,943 | から $15,000 |
Bookimedは卵巣癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。卵巣癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。卵巣癌治療の旅路でお一人になることはありません。
この医師は、高度な技術を持つ腫瘍専門医であり、固形腫瘍、小児腫瘍、血液悪性腫瘍を含むさまざまな癌の治療を専門としています。彼女は、ウィップル手術などの保守的および外科的治療の両方に精通しています。<\/p>
彼女はLady Hardinge Medical CollegeでMBBSを取得し、Maulana Azad Medical Collegeで内科のMDを取得しました。その後、Tata Memorial HospitalでDM医療腫瘍学を追求し、そこでコンサルタントとしても勤務しました。<\/p>
彼女は国際的および国内の腫瘍学会に所属しており、肺、乳房、婦人科、泌尿生殖器の癌に関する専門知識を持ち、免疫療法とメトロノミック療法に特に関心を持っています。<\/p>
この医師は、HCG Manavata Cancer Centreで12年間の経験を持つ熟練した核医学専門医です。医師は、さまざまな核スキャン、PET-CTスキャン、および核心臓病学サービスを専門としており、放射性ヨウ素およびLu-177 RN療法において熟練しています。キャリアの中で、医師は30,000件以上のPETスキャンを管理し、1,000人以上の甲状腺癌患者を治療してきました。さらに、医師はさまざまな医学雑誌に論文を発表することで、この分野に貢献しています。
Primary ovarian cancer treatments in India include cytoreductive surgery and platinum-based chemotherapy. Major JCI-accredited centers utilize advanced laparoscopic and robotic-assisted techniques to perform optimal debulking. Many institutions also provide heated intraperitoneal chemotherapy (HIPEC) and targeted therapy using PARP inhibitors for genetic mutations.
Bookimed Expert Insight: Patient volume data highlights India as a global hub for oncology expertise. HCG Manavata Cancer Centre serves over 75,000 patients annually with 40+ dedicated oncologists. Dr. Raj Nagarkar alone has performed over 40,000 cancer surgeries. This high procedural volume at accredited centers often correlates with streamlined surgical outcomes and access to specialized technologies like the Da Vinci robotic system.
Patient Consensus: Patients emphasize choosing NABH-accredited facilities to ensure high quality standards. Many note that targeted therapies are often more accessible and affordable in India compared to other regions.
The overall 5-year survival rate for ovarian cancer in India is approximately 48%. Success depends largely on the stage at diagnosis. Early-stage cases show survival rates between 93% and 94%. Conversely, advanced-stage survival ranges from 15% to 50% depending on surgical outcomes.
Bookimed Expert Insight: Data from top institutions like HCG Manavata and Apollo Hospital Indraprastha show a shift toward aggressive multimodal protocols. Surgeons like Dr. Raj Nagarkar have performed over 50,000 surgeries, emphasizing that high-volume expertise often translates to better debulking results. Patients should prioritize clinics offering integrated technologies like IBM Watson or DaVinci robotic systems to improve surgical precision.
Patient Consensus: Patients note that reaching Tier 1 cities quickly is vital since late diagnosis often lowers initial statistical odds. Many emphasize that successful debulking surgery combined with cycles of chemotherapy was the turning point in their recovery.
Indian oncology centers treat ovarian cancer using aggressive cytoreductive surgery and platinum-based chemotherapy. Specialists utilize advanced techniques like robotic-assisted surgery and Hyperthermic Intraperitoneal Chemotherapy to improve outcomes. High-volume hospitals also offer targeted therapies and immunotherapy for advanced cases within JCI-accredited facilities.
Bookimed Expert Insight: Clinical experience is a major differentiator in India, with surgeons like Dr. Raj Nagarkar performing over 50,000 cancer surgeries. This high volume allows centers like HCG Manavata Cancer Centre to successfully manage complex cases that require multidisciplinary expertise. Patients should look for facilities with specialized gynecological oncology departments rather than general surgery wings to ensure better debulking results.
Patient Consensus: Patients emphasize the importance of reaching `no visible disease` after surgery and often recommend specifically requesting debulking metrics. Many note that joining local support communities helps navigate the logistics of long-term chemotherapy and supportive care needs.
Ovarian cancer treatments like chemotherapy and surgical oophorectomy often cause permanent infertility or premature menopause. Indian oncology centers provide fertility-preserving options including egg freezing and nerve-sparing surgery for early-stage cases. Specialized units at facilities like Apollo Hospital Indraprastha coordinate these procedures alongside primary cancer care.
Bookimed Expert Insight: Success in preserving fertility often depends on hospital infrastructure rather than just surgical skill. Our data shows that top-tier institutions like Manipal Hospitals or HCG Manavata Cancer Centre integrate IBM Watson and advanced diagnostics to stage tumors with high precision. This accuracy is vital because fertility-sparing surgery is only safe if scans confirm the cancer is strictly limited to one ovary.
Patient Consensus: Patients note that standard protocols often involve removing both ovaries, so you must request a fertility consultation immediately at diagnosis. Many find that donor-egg IVF becomes the most realistic path if embryos were not banked before starting chemotherapy.
India hosts several leading hospitals for ovarian cancer care. These centers are recognized by Newsweek and JCI for their advanced gynecologic oncology departments. Facilities like Artemis, Apollo, and Medanta provide robotic-assisted surgery, HIPEC, and comprehensive genomic profiling for personalized treatment plans.
Bookimed Expert Insight: While many search for Mumbai or Delhi, specialized oncology expertise often lies in high-volume networks. For example, Dr. Raj Nagarkar at HCG Manavata has performed over 50,000 surgeries. Highly specialized doctors like Dr. Shruti Kate, a DM from Tata Memorial, lead teams in Nashik. Choosing a center where leaders trained at national benchmarks ensures high competence at lower costs.
Patient Consensus: Patients note that the speed of diagnosis and the availability of multidisciplinary tumor boards are vital. They emphasize that coordinating robotic surgery through large networks helps manage complex recoveries more effectively.
International patients typically plan for a 2 to 4 week stay in India for ovarian cancer surgery. This duration includes 5 to 7 days of hospitalization and 1 to 2 weeks of outpatient recovery. Most doctors advise waiting 10 days post-surgery before flying to ensure travel safety.
Bookimed Expert Insight: While small towns offer lower local costs, clinical data shows a benefit to choosing established hubs like Delhi or Bengaluru. Clinics like Apollo Hospital Indraprastha and Manipal Hospitals handle over 1,000,000 patients annually. High patient volume often correlates with refined surgical protocols. Dr. Raj Nagarkar at HCG Manavata has personally performed 50,000+ cancer surgeries. This level of institutional experience is vital for complex ovarian debulking procedures.
Patient Consensus: Patients note it is important to budget for extra weeks to wait for pathology results. They emphasize staying near the clinic for at least 3 weeks to manage wound healing before taking a long-distance flight.
Ovarian cancer survival in India correlates strongly with the cancer stage at diagnosis. Early-stage detection yields a 90% to 94% survival probability over 5 years. However, approximately 80% of cases are diagnosed at advanced stages. These stages show varied long-term survival from 15% to 39%.
Bookimed Expert Insight: High-volume centers like Apollo Hospitals and Manipal Hospitals handle millions of patients annually. Our data shows hospitals with dedicated surgical oncologists, such as Dr. Raj Nagarkar who has performed 50,000 procedures, maintain better outcomes. Choosing a clinic with specific gynecological oncology experts significantly impacts successful cytoreduction during surgery.
Patient Consensus: Patients note that choosing private centers often leads to better relapse-free survival compared to public facilities. Many emphasize that BRCA testing and consistent CA-125 monitoring are vital for managing recurrence risks.
Medical travelers should plan for a 2 to 6 week stay in India for ovarian cancer treatment. This period covers pre-operative assessments, specialized surgery, and initial recovery. Duration varies based on whether treatments like HIPEC or intensive chemotherapy are required alongside primary surgical interventions.
Bookimed Expert Insight: Data from hub cities like Mumbai and Delhi shows that 10% to 20% of patients benefit from adding a 2-week buffer to their initial plan. Leading centers such as HCG Manavata, where Dr. Raj Nagarkar has performed over 50,000 surgeries, often manage complex cases that require extra monitoring for pathology results and healing. Factoring in this buffer ensures you are cleared by an oncologist before the long flight home.
Patient Consensus: Patients emphasize booking extended-stay accommodation near the hospital to manage recovery comfortably. It is often noted that planning for tele-oncology helps transition treatment back home after the first few weeks.
Ovarian cancer care should be overseen by a gynecologic oncologist. These specialists are obstetrician-gynecologists with advanced fellowship training in female reproductive cancers. In India, leading centers like HCG Manavata Cancer Centre and Manipal Hospitals employ experts specializing in complex surgical and medical oncology protocols.
Bookimed Expert Insight: Patient volume is a major indicator of surgical proficiency in India. Dr. Raj Nagarkar at HCG Manavata Cancer Centre has performed over 50,000 cancer surgeries. Clinics like Manipal Hospitals serve 2,000,000 patients annually. High-volume specialists typically offer better outcomes in complex procedures like cytoreductive surgery and HIPEC.
Patient Consensus: Patients emphasize that a gynecologic oncologist must lead the surgery rather than a general surgeon. They recommend asking how many debulking procedures the surgeon performs yearly to ensure the best results.
Ovarian cancer treatment in India follows global protocols. These include cytoreductive surgery and platinum-based chemotherapy. Specialists use robotic systems and platforms like HIPEC for abdominal tumours. Leading JCI-accredited centres like Artemis and Apollo Hospitals provide integrated care for all stages.
Bookimed Expert Insight: Indian cancer centres often use AI-driven decision support like IBM Watson at Manipal Goa. This technology helps oncologists select specific drug protocols based on global clinical data. Patients benefit from this specialised planning, which is often rare even in private Western clinics.
Patient Consensus: Patients value seeing a specialised gynaecologic oncologist rather than a general surgeon. They also appreciate quick access to staging and biopsies in India to start treatment immediately.
Indian oncology centres use imaging and molecular profiling to plan ovarian cancer treatment. Key tools include FDG PET/CT for staging and CT PAUSE scoring to predict surgical success. Next-generation sequencing is also used. These tools help specialists decide between immediate surgery or starting with chemotherapy.
Bookimed Expert Insight: Quality markers in India often align with international standards. Major hospitals like Artemis and Apollo hold JCI accreditation. This is the same gold standard used in Australia. Dr Chaitainya Borde at HCG Manavata has managed over 30,000 PET scans. This high volume drives local diagnostic expertise.
Patient Consensus: Patients note that combining PET-CT scans with CA-125 blood tests and biopsy results provides a clear roadmap. They appreciate how multidisciplinary teams review these reports to choose between chemotherapy or robot-assisted surgery.
Fertility preservation is possible for early-stage ovarian cancer in India through fertility-sparing surgery and cryopreservation. Specialists at Joint Commission International-accredited centres like Apollo Hospital Indraprastha and Manipal Hospitals perform unilateral salpingo-oophorectomy for Stage 1 cases. This preserves the uterus and one healthy ovary.
Bookimed Expert Insight: India ranks 9th globally for medical requests. This is partly due to the high volume at centres like HCG Manavata Cancer Centre. This centre treats over 75,000 patients annually. Large networks like Apollo and Manipal integrate oncology with IVF labs on-site. This coordination allows for rapid egg or embryo freezing before intensive treatment begins.
Patient Consensus: Patients in India recommend a joint consultation between oncologists and fertility specialists before the first surgery. It is critical to secure this plan early. Standard cancer operations usually prioritise total removal over future reproductive goals.
Indian oncology centres manage ovarian cancer care through multidisciplinary teams led by gynaecologic oncologists. These teams use integrated tumour boards to coordinate surgery, systemic therapies, and diagnostics like PET-CT. Accredited tertiary hospitals provide care pathways from initial staging through to complex cytoreductive surgery.
Bookimed Expert Insight: Indian oncology is shifting toward precision technology. Manipal Goa Hospital now uses IBM Watson to support oncology decisions. This provides data-backed treatment roadmaps that align with international standards. Centres like HCG Manavata Cancer Centre also employ specialised nuclear medicine doctors. These doctors have reviewed over 30,000 PET scans to ensure accurate staging for complex cases.
Patient Consensus: Patients note that treatment in India works best when one integrated centre manages the full pathway. They recommend having a dedicated contact person for reports and scheduling. This helps prevent communication gaps between surgical and chemotherapy teams.
Australians travelling to India for ovarian cancer treatment must obtain an e-Medical Visa. This requires an official invitation letter from an accredited Indian hospital. Passports must have six months of validity. Travellers must also follow medication protocols and airline medical clearance rules before departure.
Bookimed Expert Insight: Indian oncology centres like Apollo Hospital Indraprastha and Manipal Hospitals maintain JCI and NABH accreditations. These standards align with international quality expectations. Data shows major networks treat over 1,000,000 patients annually. This high volume often leads to faster diagnostic turnaround for complex cases compared to Australian waiting lists.
Patient Consensus: Patients note it is vital to secure the treatment letter early for visa approval. Confirming telehealth follow-up with Indian clinicians helps manage the transition back to Australian oncology teams.